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Objective: Carotid Angioplasty combined with Stenting (CAS) is
increasingly performed because of its presumed benefits. A study was per-
formed to identify key factors that determine the cost-effectiveness as
compared to conventional carotid endarterectomy (CEA).
Methods: The incremental cost-effectiveness of CAS over CEA for
different scenarios was estimated using a modeling approach. Treatment
costs were based on actual costs of successful procedures whereas costs of
complications were taken from the literature. Patient survival was modeled
using the endarterectomy patients from the ECST trial.
Results: Procedural costs of CAS are higher than those of CEA, mainly
as a result of the high material costs. Cost-effectiveness of CAS primarily
depends on major stroke rates. One percent increase in the peri-operative
major stroke rate causes a cost increase of €1 051 and a loss of 0.06 quality
adjusted life years.
Conclusions:At present CAS is at best non-inferior to CEA in terms of
clinical outcome. Cost savings due to shorter admission are offset by the high
costs associated with catheter-based interventions. At present CAS should be
restricted to controlled settings until clinical trials have shown a substantial
clinical benefit.
Multidimensional Characterization of Carotid Artery Stenosis Using
CT Imaging: A Comparison with Ultrasound Grading and Peak Flow
Measurement
van Prehn J., Muhs B.E., Pramanik B., Ollenschleger M., Rockman C.B.,
Cayne N.S., Adelman M.A., Jacobowitz G.R., Maldonado T.S. Eur J Vasc
Endovasc Surg 2008;36:267-72.
Purpose: Clinical decision making for carotid surgery depends largely
upon stenosis grade. While digital subtraction angiography remains the gold
standard for stenosis grading, many physicians use less invasive modalities.
The purpose of this study was to compare the results of multidimensional
Computed tomography (CTA) with ultrasound (US) grading and peak flow
velocity (PSV).
Methods: 37 stenosed carotid arteries were studied retrospectively in
36 consecutive patients. US grading and PSV were compared to multidi-
mensional CTA analysis (diameter, area and volumetric measurements),
performed by a medical software company. Calculations of stenosis percent-
age on CTA were made using the NASCET and ECST methodology.
Diameter measurements were also performed by a neuroradiologist.
Results: All CTA diameter, area and volume measurements had only
modest correlation with PSV (r  0.5) and ultrasound grading (p  0.5).
There was concordant classification of stenosis grades in only 40–60% of
cases. CTA diameter, area and volume measurements had good correlation
(0.69  r  0.87) with one another using ECST methodology. Using
NASCETmethodology on CTA, correlation between diameter and area was
insignificant (r  0.32). CTA volumetric analysis with the NASCET
method yielded 27 negative stenosis grades. Repeatability coefficient for
selecting the normal distal ICA 20 mm more distally was 20% for diameter
and 43% for area. CTA diameter interobserver repeatability coefficients were
22.9% (NASCET) and 17.8% (ECST) and 0.7 mm (lumen) and 1.9 mm
(vessel).
Conclusions: All CTA measurements showed moderate correlation
with both ultrasound grading and PSV. Selection of the level of the
normal distal ICA influences the NASCET calculations and can produce
discrepant stenosis grades. Multidimensional CTA analysis seems to have
no additional value for stenosis grading, but provides other useful
anatomic information.
Potential Circulating Biomarkers for Abdominal Aortic Aneurysm
Expansion and Rupture - a Systematic Review
Urbonavicius S., Urbonaviciene G., Honoré B., Henneberg E.W., Vorum
H., Lindholt J.S. Eur J Vasc Endovasc Surg 2008;36:273-80.
Background: The maximal diameter of abdominal aortic aneurysms
(AAAs) is the dominating indication for repair. However half of the AAAs
repaired would never have ruptured if left unrepaired, although small AAAs
772occasionally rupture. Earlier surgery may be associated with a lower mortal-
ity. More precise indicators for surgery are warranted. This systematic review
identifies potential systemic biomarkers for AAA rupture or expansion.
Methods: MEDLINE/PubMed and EMBASE (from 1985 trough
May 2007) were searched with themedical subject heading abdominal aortic
aneurysm and keywords “size”, “progression” or “growth” or “expansion
rate” or “rupture” on the basis of MESH tree and as a text search restricted
to English, German, French and Italian. In addition, reference lists were
studied and manual searches performed. Observational studies investigating
the association of circulating biomarkers with AAA rupture, expansion or
size were selected.
Data extraction: Two reviewers (SU and GU) independently ex-
tracted the following data: year of publication, study characteristics, dura-
tion of follow-up, circulating biomarker, AAA expansion rate or size or
rupture.
Results: 699 papers were identified. After exclusion of thoracic aneu-
rysms and cardiac studies (n  118), surgical or medical treatment studies
(n  179), case reports and animal studies (n  87), as well as reviews or
letters (n  66), 249 articles were selected. Also excluded were 230 papers
that did not report AAA size, expansion rate or rupture. 39 papers were
included. Several potential biomarkers were identified. The strongest asso-
ciation with AAA was obtained with serum elastin peptides (SEP) and
plasmin-antiplasmin (PAP) complexes. Matrix-degrading metalloproteinase
9 (MMP9) and interferon-gamma (IFN-gamma) could have clinical poten-
tial while many putative biomarkers showed poor association.
Conclusions: Several circulating agents in peripheral blood may pre-
dict AAA size, expansion rate or rupture. Few of them have clinical potential
for future use. Confirmative studies and development of multivariate models
are needed, together with continuing search for new biomarkers using the
discovery based sciences within proteomics and/or genomics.
Abdominal Aortic Aneurysm and the Impact of Infectious Burden
Nyberg A., Skagius E., Englund E., Nilsson I., Ljungh Å., Henriksson A.E.
Eur J Vasc Endovasc Surg 2008;36:292-6.
Objectives: Little is known about the biological processes causing
aortic aneurysm rupture. Chronic Chlamydophila pneumoniae infection
has been suggested as a possible contributing factor to the development
and expansion of abdominal aortic aneurysm (AAA). The importance
of infection in AAA may be related to the previous pathogen burden,
that is, the number of significant titres of antibodies against infectious
pathogens rather than to single infectious agents. The aim of this study
was to examine the relationship between infectious burden and AAA
rupture.
Methods: In a case-control study, 119 patients with abdominal aortic
aneurysm and 36 matched controls without aneurysm were prospectively
investigated for specific IgG class antibodies against C. pneumoniae,Helico-
bacter pylori, Cytomegalovirus, and Herpes simplex virus.
Results: Patients with ruptured AAA have similar levels of pathogen
burden as patients with nonruptured electively operated AAA, small AAA,
and controls without aneurysm.
Conclusion: The present study fails to demonstrate a connection
between infectious burden and abdominal aortic aneurysm rupture.
Remote Endarterectomy for Long Segment Superficial Femoral Artery
Occlusive Disease. A Systematic Review
Antoniou G.A., Koutsias S., Antoniou S.A., Giannoukas A.D. Eur J Vasc
Endovasc Surg 2008;36:310-8.
Background: Remote endarterectomy is a minimally invasive proce-
dure which combines open and endovascular surgery for the treatment of
long segment superficial femoral artery (SFA) occlusive disease. We con-
ducted a systematic review of the medical literature to analyze the indica-
tions, technical limitations and the outcome of remote SFA endarterectomy
(RSFAE).
Methods: The English literature was searched using the MEDLINE
electronic database up to February 2008. We considered studies comprising
at least 10 patients treated with RSFAE and reporting on the primary and/or
secondary patency rates. Average primary and secondary patency rates were
obtained by weighting the data of each study by the number of limbs treated.Results: Our search identified 19 retrospective or prospective case
series; no randomized controlled trials comparing RSFAE with another
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94% and the procedure-related complication rate was 14.7%. The weighted
mean cumulative primary patency rates were 60%, 57% and 35% at 1, 2 and
5 years, respectively. The weighted mean assisted primary patency rates were
75%, 77% and 50% at 1, 2 and 5 years, respectively. The weighted mean
secondary patency rates were 88% and 62% at 1 and 2 years, respectively.
Conclusions: RSFAE has acceptable short-, medium- and long-term
results but patients should undergo intensive surveillance postoperatively.
Randomized controlled trials are needed to assess the durability of this
procedure as compared to conventional open bypass surgery.
Angioplasty for Diabetic Patients with Failing Bypass Graft or Residual
Critical Ischemia after Bypass Graft
Faglia E., Clerici G., Clerissi J., Caminiti M., Quarantiello A., Curci V., Losa
S., Vitiello R., Lupattelli T., Somalvico F. Eur J Vasc Endovasc Surg
2008;36:331-8.
Objective: To evaluate the efficacy of peripheral angioplasty (PTA) in
the treatment of diabetic patients with previous peripheral bypass graft and
recurrent critical limb ischemia (CLI).
Methods: Between January andDecember 2006, 293 diabetic patients
presenting with critical limb ischemia (CLI) according to the TASC 2000
criteria were admitted to our footcare centre. Among these patients, 32 of
them had previously undergone bypass grafting: femoropopliteal in 26
patients, femoroposterior tibial in 3 patients, femoroperoneal in the remain-
ing 3. All these patients underwent angiography and, whenever possible, a
concomitant PTA procedure.
Results: Six patients presented with stenosis at the distal anastomosis,
2 with stenosis at the proximal anastomosis and in 5 patients both the distal
and proximal anastomosis were stenosed. In 12 patients the graft was
completely occluded. In 7 patients the graft appeared patent but all the
infrapopliteal arteries were occluded. The average time interval between
bypass and subsequent hospital admission because of CLI was 6.3  4.2
months for patients with patent grafts and 20.5  12.0 months for those
with failing grafts (p  0.004).
A successful PTA was performed in 25 patients (78.1%). In all patients
with patent grafts, PTA recanalized one infrapopliteal artery. Recanalization
of the graft was obtained in all 13 patients with non-occluded graft.
Recanalization of superficial femoral artery occlusion by means of PTA was
obtained in 5 out of the 12 patients in whom the graft was completely
occluded. Five patients underwent major amputation within 30 days and 3
further patients during the follow-up period. Patients were followed up until
December 31 2007, with a mean follow-up of 1.89  0.27 years. Restenosis
occurred in 7 (28.0%) of the 25 patients in whom a successful PTA was
performed. In 5 of these 7 patients, PTA was repeated successfully. In 2
patients in whom a further PTA was not feasible a major amputation was
performed. At the end of the follow-up period the cumulative primary
patency rate was 72%, the assisted patency rate was 92%.
Conclusions: PTA is an effective method for revascularizing secondary
obstructions in patients with graft failure (and no possibility of a redo graft).
PTA also is effective in at least one subgenicular artery in patients with
diabetes with inadequate run-off after femoropopliteal bypass grafting.
The Incidence of Arterial Stent Fractures with Exclusion of Coronary,
Aortic, and Non-arterial SettingsReaders can access EJVES articles at http://intl.eBackground: This study aimed to review the literature regarding
fracture of arterial stents, especially its relation to location of placement,
clinical relevance, and type of stents.
Material and methods:We searched published articles in PubMed up
to February 2008 by using the terms: stent fracture or stent breakage.
Results: Thirty-one articles met our inclusion and exclusion criteria.
Most of the studies reported fractures in stents placed in the superficial
femoral artery or popliteal arteries. The cumulative incidence of stent
fractures ranged from 2% to 65%, i.e. 0.6 to 60 per 1000 person-months.
Stent fractures occur more frequently in the superficial femoral artery and
are common when multiple stents are deployed and overlap. Stent
fractures are associated with a higher risk of in–stent restenosis and
re-occlusion.
Conclusion: The incidence of stent fracture, its location of placement,
and type of stent used were diverse across studies. Stent fracture may cause
clinical deterioration especially in the femoropopliteal segment, and it
should be detected before clinical manifestation appears. Further studies
with larger study population involving new type of stents for a longer follow
up period are warranted.
Secondary Patency of Thrombosed Prosthetic Vascular Access
Grafts with Aggressive Surveillance, Monitoring and Endovascular
Management
Kakkos S.K., Haddad G.K., Haddad J.A., Scully M.M. Eur J Vasc Endovasc
Surg 2008;36:356-65.
Background: To study the long-term patency of thrombosed pros-
thetic vascular access grafts treated with percutaneous mechanical throm-
bectomy (PMT) followed by aggressive surveillance and monitoring and
repeated endovascular interventions.
Study design:Two hundred seven vascular access grafts presented with
first-time thrombosis were treated with PMT using the AngioJet device
(n  185) or the Arrow-Trerotola percutaneous thrombolytic device
(n  22) followed by angioplasty ( stenting) of the anatomical lesion
responsible for the thrombotic event. Clinical success was considered at least
one successful subsequent hemodialysis session. Graft surveillance/monitor-
ing included clinical and hemodialysis parameters to detect a failing or
thrombosed graft.
Results: PMT was technically successful in 202 cases (97.6%) and
clinically successful in 193 cases (93.2%). During follow-up, 149 got throm-
bosed and either abandoned (n  33) or underwent at least once repeat
thrombectomy (n  116); finally 100 grafts were abandoned (n  90),
ligated (n  5) or removed (n  5). Endovascular management (0.54 pro-
cedures per 100 graft-days, thrombectomy, n  307 sessions and angio-
plasty, n  162 sessions) increased significantly functional assisted-primary
patency rates from 29% and 14% at 1 and 2 years to a secondary patency of
62% and 47%, respectively. Secondary patency was worse in loop grafts
(P  .02) and intermediate graft thrombosis (occurred between 31–182
days after graft placement, P  .001) and better when renal failure was due
to hypertension or diabetes (compared to other or cryptogenic causes,
P  .048) or isolated angioplasty for graft dysfunction during follow-up had
been performed (P  .001). Multivariate analysis identified intermediate
graft thrombosis and isolated angioplasty as independent predictors of
secondary patency (P  .001, relative risk 2.77 and P  .001, relative risk
0.28, respectively).
Conclusions: PMT is a highly successful procedure with acceptable
long-term secondary patency results, provided that aggressive endovascular
management of subsequent thrombotic or dysfunction episode is per-Rits J., van Herwaarden J.A., Jahrome A.K., Krievins D., Moll F.L. Eur J
Vasc Endovasc Surg 2008;36:339-45.
formed. Further research to identify the causes of intermediate graft throm-
bosis is justified.lsevierhealth.com/journals/ejvs/default.cfm
